ArticleNature communications2021

Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.

Rosa Andres-Ejarque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.